Pharsight

Drugs that contain Fingolimod Lauryl Sulfate

1. Tascenso Odt patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10555902 HANDA Stable fingolimod dosage forms
Jan, 2036

(11 years from now)

US9925138 HANDA Stable solid fingolimod dosage forms
Jan, 2036

(11 years from now)

US10925829 HANDA Stable solid fingolimod dosage forms
Jan, 2036

(11 years from now)

Market Authorisation Date: 23 December, 2021

Treatment: Treatment of multiple sclerosis in pediatric patients 10 years of age and older and weighing less than or equal to 40 kg

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage

TASCENSO ODT family patents

Family Patents